Name Net increased
positions
Increased positions Reduced positions Return since
31 Mar ‘23
1
50 117 67 99.1%
2
36 69 33 89.2%
3
36 94 58 91.2%
SGMO icon
4
Sangamo Therapeutics
SGMO
$107M
35 75 40 85.3%
5
34 98 64 97.8%
6
33 85 52 80.2%
7
32 57 25 92.6%
8
32 64 32 72%
9
30 89 59 89.6%
10
30 58 28 93%
REPL icon
11
Replimune Group
REPL
$187M
29 64 35 87.1%
12
29 70 41 90.4%
13
27 57 30 95.2%
14
27 107 80 89.4%
15
26 31 5 100%
16
26 63 37 42.7%
17
26 29 3 96.2%
18
26 34 8 98.7%
19
25 59 34 86.2%
20
24 47 23 88.4%
21
24 126 102 96.6%
22
24 46 22 75.1%
23
24 31 7 94%
24
24 53 29 84.4%
25
23 51 28 82%